Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 14/20 | 0.60 |
| ▸ | NPY1R | P25929 | 8/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.60 |
| ▸ | NPY2R | P49146 | 5/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.57 |
| ▸ | VIPR2 | P41587 | 3/20 | 0.55 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29857653 | 0.94 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL11886067 | 0.94 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29458835 | 0.94 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30827582 | 0.92 | NPY4R (0.70) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL9401494 | 0.91 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29521070 | 0.91 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29767743 | 0.91 | NPY4R (0.69) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL17915900 | 0.91 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29972930 | 0.91 | KISS1R (0.62) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30974441 | 0.90 | VIPR2 (0.63) | KISS1RVIPR2VIPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116333091-A | Method for preparing HGH (176-191) by continuous flow solid phase synthesis | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116333091-A | Method for preparing HGH (176-191) by continuous flow solid phase synthesis | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-27 | — | — | CN | disclosed |